[Medication of the month. Duloxetine (Cymbalta)]

Rev Med Liege. 2006 Nov;61(11):787-90.
[Article in French]

Abstract

Duloxetine (Cymbalta is an antidepressant of the class of serotonin noradrenaline reuptake inhibitors. The efficacy of duloxetine 60 mg/day has been well demonstrated in the acute and long term treatment of major depression. The level of effectiveness of duloxetine is particularly high and associated with a shorter latency of action. Duloxetine also exhibits antinociceptive properties independently of the antidepressant effect. The side-effect profile of duloxetine is particularly good and similar to selective serotonin reuptake inhibitors with mainly nausea. In total, duloxetine represents a real progress in the pharmacological treatment of major depression.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Antidepressive Agents / pharmacology*
  • Depression / drug therapy
  • Duloxetine Hydrochloride
  • Humans
  • Thiophenes / pharmacology*

Substances

  • Antidepressive Agents
  • Thiophenes
  • Duloxetine Hydrochloride